| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Coactivator 1 | 11 | 2019 | 162 | 0.900 |
Why?
|
| Trans-Activators | 11 | 2019 | 692 | 0.760 |
Why?
|
| Nuclear Receptor Coactivator 3 | 15 | 2015 | 257 | 0.730 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2015 | 323 | 0.640 |
Why?
|
| Histone Acetyltransferases | 10 | 2008 | 224 | 0.620 |
Why?
|
| Twist-Related Protein 1 | 5 | 2023 | 35 | 0.450 |
Why?
|
| Mice | 48 | 2024 | 18473 | 0.400 |
Why?
|
| Mice, Knockout | 24 | 2021 | 3861 | 0.400 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 2 | 2024 | 32 | 0.400 |
Why?
|
| Mice, Transgenic | 12 | 2024 | 2363 | 0.380 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2015 | 43 | 0.360 |
Why?
|
| Animals | 48 | 2024 | 34341 | 0.300 |
Why?
|
| Transcription Factors | 11 | 2014 | 2436 | 0.300 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2015 | 31 | 0.300 |
Why?
|
| Gene Editing | 2 | 2024 | 229 | 0.290 |
Why?
|
| Nuclear Proteins | 6 | 2023 | 1226 | 0.290 |
Why?
|
| CRISPR-Cas Systems | 2 | 2024 | 310 | 0.280 |
Why?
|
| Breast Neoplasms | 10 | 2016 | 2646 | 0.280 |
Why?
|
| Prostatic Neoplasms | 5 | 2019 | 1417 | 0.260 |
Why?
|
| Liver | 4 | 2021 | 1795 | 0.260 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2017 | 611 | 0.260 |
Why?
|
| Growth Hormone | 1 | 2006 | 127 | 0.240 |
Why?
|
| Growth Disorders | 1 | 2006 | 184 | 0.220 |
Why?
|
| Embryonic Stem Cells | 3 | 2009 | 160 | 0.210 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2015 | 237 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2009 | 329 | 0.200 |
Why?
|
| Hypothalamus | 3 | 2023 | 205 | 0.200 |
Why?
|
| Spermatogenesis | 3 | 2015 | 171 | 0.190 |
Why?
|
| Mammary Glands, Animal | 7 | 2013 | 447 | 0.190 |
Why?
|
| Oocytes | 2 | 2024 | 283 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2023 | 181 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 289 | 0.180 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 9 | 0.180 |
Why?
|
| Phenylketonurias | 1 | 2021 | 15 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 2355 | 0.170 |
Why?
|
| Phenylalanine | 1 | 2021 | 126 | 0.170 |
Why?
|
| Memory | 1 | 2024 | 358 | 0.170 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2017 | 135 | 0.170 |
Why?
|
| Cell Line, Tumor | 10 | 2019 | 3672 | 0.160 |
Why?
|
| Repressor Proteins | 4 | 2011 | 777 | 0.160 |
Why?
|
| Neoplasms | 4 | 2023 | 2969 | 0.160 |
Why?
|
| Estradiol | 4 | 2015 | 481 | 0.160 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 207 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 165 | 0.160 |
Why?
|
| Neoplasm Metastasis | 3 | 2015 | 711 | 0.150 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2019 | 8 | 0.150 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 160 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 999 | 0.150 |
Why?
|
| Glucose | 1 | 2023 | 848 | 0.150 |
Why?
|
| Organ Specificity | 3 | 2013 | 400 | 0.150 |
Why?
|
| Embryonic Development | 1 | 2020 | 225 | 0.140 |
Why?
|
| Cell Movement | 4 | 2017 | 879 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2017 | 1988 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2021 | 230 | 0.140 |
Why?
|
| RNA, Messenger | 7 | 2012 | 2567 | 0.140 |
Why?
|
| Crosses, Genetic | 4 | 2019 | 155 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 4 | 2017 | 647 | 0.140 |
Why?
|
| Female | 33 | 2024 | 71087 | 0.140 |
Why?
|
| Transcription Factor AP-1 | 2 | 2015 | 112 | 0.140 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 73 | 0.140 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2015 | 150 | 0.130 |
Why?
|
| Prealbumin | 2 | 2008 | 27 | 0.130 |
Why?
|
| Cell Plasticity | 1 | 2017 | 37 | 0.130 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 160 | 0.130 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2014 | 17 | 0.130 |
Why?
|
| Neurons | 3 | 2024 | 1990 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 634 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 876 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 428 | 0.120 |
Why?
|
| Uterus | 3 | 2012 | 546 | 0.120 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 1541 | 0.120 |
Why?
|
| Estrogens | 2 | 2012 | 436 | 0.120 |
Why?
|
| Receptors, Estrogen | 4 | 2009 | 722 | 0.120 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 1397 | 0.120 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 52 | 0.120 |
Why?
|
| Sexual Behavior, Animal | 1 | 2015 | 60 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 8 | 2011 | 4763 | 0.120 |
Why?
|
| Nuclear Receptor Coactivators | 3 | 2012 | 60 | 0.120 |
Why?
|
| HEK293 Cells | 4 | 2022 | 809 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 95 | 0.110 |
Why?
|
| Male | 23 | 2024 | 65158 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 235 | 0.110 |
Why?
|
| Gene Expression | 6 | 2013 | 1500 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 135 | 0.110 |
Why?
|
| Morphogenesis | 2 | 2013 | 198 | 0.100 |
Why?
|
| Bufanolides | 1 | 2014 | 13 | 0.100 |
Why?
|
| Body Weight | 4 | 2019 | 986 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 240 | 0.100 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 59 | 0.100 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 2 | 2024 | 15 | 0.100 |
Why?
|
| Health | 1 | 2013 | 35 | 0.100 |
Why?
|
| Hair Follicle | 1 | 2013 | 33 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 341 | 0.100 |
Why?
|
| Reproduction | 1 | 2015 | 215 | 0.100 |
Why?
|
| Hepatocytes | 2 | 2021 | 234 | 0.100 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2012 | 35 | 0.100 |
Why?
|
| Serotonin | 2 | 2024 | 212 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 189 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 356 | 0.090 |
Why?
|
| Signal Transduction | 6 | 2013 | 4674 | 0.090 |
Why?
|
| Receptors, Somatotropin | 1 | 2011 | 9 | 0.090 |
Why?
|
| Obesity | 2 | 2022 | 2379 | 0.090 |
Why?
|
| Integrin alpha5 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Liver Regeneration | 1 | 2011 | 39 | 0.090 |
Why?
|
| Protein Binding | 4 | 2021 | 1710 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 88 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 106 | 0.080 |
Why?
|
| Aging | 3 | 2015 | 1264 | 0.080 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2010 | 16 | 0.080 |
Why?
|
| Embryo Implantation | 1 | 2012 | 230 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2023 | 262 | 0.080 |
Why?
|
| Serine | 1 | 2011 | 163 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 514 | 0.080 |
Why?
|
| Lactation | 1 | 2011 | 197 | 0.080 |
Why?
|
| MCF-7 Cells | 3 | 2015 | 209 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 672 | 0.080 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 23 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 588 | 0.080 |
Why?
|
| Cell Division | 4 | 2004 | 725 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 1236 | 0.080 |
Why?
|
| Cell Proliferation | 5 | 2017 | 2464 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 296 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1610 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 88 | 0.070 |
Why?
|
| Exons | 2 | 2018 | 768 | 0.070 |
Why?
|
| Humans | 20 | 2024 | 131504 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 139 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2019 | 1945 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 279 | 0.070 |
Why?
|
| RNA Interference | 3 | 2015 | 496 | 0.070 |
Why?
|
| Apoptosis | 6 | 2013 | 1861 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 272 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2015 | 291 | 0.060 |
Why?
|
| Dwarfism | 1 | 2008 | 108 | 0.060 |
Why?
|
| Alleles | 3 | 2019 | 1709 | 0.060 |
Why?
|
| Receptors, Androgen | 3 | 2019 | 418 | 0.060 |
Why?
|
| Pregnancy | 5 | 2020 | 7572 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2009 | 297 | 0.060 |
Why?
|
| Histones | 1 | 2009 | 518 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 414 | 0.060 |
Why?
|
| Human Growth Hormone | 1 | 2006 | 75 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2009 | 1024 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 200 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 692 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2019 | 579 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 486 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2015 | 54 | 0.050 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2004 | 76 | 0.050 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2004 | 84 | 0.050 |
Why?
|
| Testis | 2 | 2004 | 413 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2005 | 448 | 0.050 |
Why?
|
| Zygote | 1 | 2024 | 29 | 0.050 |
Why?
|
| Genotype | 3 | 2008 | 2655 | 0.050 |
Why?
|
| Sertoli Cells | 1 | 2004 | 76 | 0.050 |
Why?
|
| Genes, ras | 1 | 2004 | 99 | 0.050 |
Why?
|
| Growth | 1 | 2004 | 92 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2006 | 305 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4684 | 0.050 |
Why?
|
| Anoctamins | 1 | 2023 | 13 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 71 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2015 | 239 | 0.050 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2023 | 24 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 172 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2015 | 694 | 0.050 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 20 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 332 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 73 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2011 | 1570 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 208 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 89 | 0.050 |
Why?
|
| Gene Knockout Techniques | 2 | 2014 | 136 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2002 | 34 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2002 | 57 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2002 | 135 | 0.050 |
Why?
|
| Cell Line | 3 | 2014 | 2603 | 0.050 |
Why?
|
| Introns | 1 | 2002 | 287 | 0.040 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 11 | 0.040 |
Why?
|
| Disease Progression | 4 | 2015 | 2205 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 785 | 0.040 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2014 | 99 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 579 | 0.040 |
Why?
|
| Heterozygote | 2 | 2019 | 728 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 723 | 0.040 |
Why?
|
| Purkinje Cells | 1 | 2003 | 170 | 0.040 |
Why?
|
| Superovulation | 1 | 2020 | 12 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 180 | 0.040 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 24 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 56 | 0.040 |
Why?
|
| Blastocyst | 1 | 2020 | 77 | 0.040 |
Why?
|
| Embryo Transfer | 1 | 2020 | 53 | 0.040 |
Why?
|
| Ovary | 1 | 2003 | 361 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 665 | 0.040 |
Why?
|
| Cell Survival | 2 | 2015 | 853 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2019 | 773 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 751 | 0.040 |
Why?
|
| Motor Activity | 1 | 2003 | 508 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 435 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 1217 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 1025 | 0.040 |
Why?
|
| Chromatin | 1 | 2002 | 491 | 0.040 |
Why?
|
| Keratin-14 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Epithelial Cells | 3 | 2011 | 900 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 805 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2023 | 1102 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 122 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 261 | 0.040 |
Why?
|
| Placenta | 1 | 2002 | 529 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2019 | 297 | 0.030 |
Why?
|
| Models, Biological | 1 | 2002 | 1390 | 0.030 |
Why?
|
| Leptin | 1 | 2019 | 218 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2011 | 439 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 630 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 483 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 588 | 0.030 |
Why?
|
| Mutation | 2 | 2024 | 6177 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 93 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2011 | 832 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2015 | 18 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2012 | 434 | 0.030 |
Why?
|
| Antibodies | 2 | 2009 | 357 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 297 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 111 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 233 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2014 | 19 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 111 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 230 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 713 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 124 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2014 | 18 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 319 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 929 | 0.030 |
Why?
|
| Pituitary Gland | 2 | 2005 | 79 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2014 | 64 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 37 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1085 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 260 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 78 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 21 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 366 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2013 | 52 | 0.020 |
Why?
|
| Gene Targeting | 2 | 2005 | 170 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 433 | 0.020 |
Why?
|
| Ovariectomy | 2 | 2004 | 163 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3454 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 518 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 70 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 1001 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1557 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 81 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 254 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 34 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 97 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 704 | 0.020 |
Why?
|
| G1 Phase | 1 | 2011 | 65 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 909 | 0.020 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 15 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 804 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 323 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 530 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 312 | 0.020 |
Why?
|
| Copulation | 1 | 2009 | 7 | 0.020 |
Why?
|
| Autoantigens | 1 | 2010 | 104 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2009 | 23 | 0.020 |
Why?
|
| Spermatids | 1 | 2009 | 26 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 227 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 666 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2012 | 358 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 119 | 0.020 |
Why?
|
| Oligospermia | 1 | 2009 | 65 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2007 | 2970 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 305 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Methylation | 1 | 2009 | 200 | 0.020 |
Why?
|
| Cadherins | 1 | 2010 | 178 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 38 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4517 | 0.020 |
Why?
|
| Stem Cells | 2 | 2005 | 712 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1018 | 0.020 |
Why?
|
| Rabbits | 1 | 2009 | 633 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 286 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 361 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1276 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 451 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 372 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2006 | 436 | 0.010 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 62 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 52 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 109 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2005 | 18 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 129 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 1022 | 0.010 |
Why?
|
| Complement C3 | 1 | 2005 | 43 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1487 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 24 | 0.010 |
Why?
|
| Haploidy | 1 | 2004 | 19 | 0.010 |
Why?
|
| Prostate | 1 | 2007 | 415 | 0.010 |
Why?
|
| Lactoferrin | 1 | 2005 | 76 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 749 | 0.010 |
Why?
|
| Sperm Count | 1 | 2004 | 92 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 549 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 138 | 0.010 |
Why?
|
| Death | 1 | 2004 | 77 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2003 | 46 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 61 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2003 | 111 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 515 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 42 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 25 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 2782 | 0.010 |
Why?
|
| Placentation | 1 | 2002 | 59 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 136 | 0.010 |
Why?
|
| Child | 1 | 2022 | 26239 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 217 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2004 | 258 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 600 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 275 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 350 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 426 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 230 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 680 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 259 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2003 | 510 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 469 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 1956 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 864 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3614 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6273 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 3237 | 0.010 |
Why?
|